Drug Research
Strict Steps In Supply Chain Against Contamination By WHO
The World Health Organization has urged regulators, suppliers, as well as medicine manufacturers to take strict steps against medicines in the supply chain that are contaminated. This is due to the recent instances of over-the-counter cough syrups which had...
Drug Research
Novel Method On Large DNA Sequences Insertion Successful
Recent work by researchers at Massachusetts General Hospital (MGH) in the US has improved the accuracy of inserting long DNA fragments into genomes.
This method might be used to introduce an entire wild-type or normal substitute gene, acting as a...
Drug Research
EyePoint Pharmaceuticals to Build GMP Mfg. Facility in Northbridge, MA
EyePoint Pharmaceuticals, Inc., a company developing and commercializing therapeutics for serious eye disorders, has entered into a lease agreement to design and construct a 40,000-sq.-ft. manufacturing facility in Northbridge, MA to support the global manufacturing of programs, including EYP-1901...
Drug Research
CytoReason Licenses IBD Disease Model to Sanofi in Expanded Alliance
CytoReason, a pioneer in computational disease modeling, expanded its collaboration with Sanofi. The multiyear collaboration will further Sanofi’s target discovery efforts via CytoReason’s AI platform in the field of inflammatory bowel disease (IBD), to identify patient subtypes and pair...
Drug Research
The EU Antibiotic Shortage Is Being Monitored Very Closely
The current EU antibiotic shortages are being closely watched, according to the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), which has also declared that it is taking action.
Through the Executive Steering Group on Shortages and...
Drug Research
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, Inc.,a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, today announced a new strategic partnership with Syneos Health® (NASDAQ: SYNH), the only fully...
Drug Research
FDA Looks To Make Edits To The Current COVID-19 Vaccines
The US FDA intends to simplify the COVID-19 vaccine process to make it look more like what happens in case of flu vaccine.This could include streamlining the composition of the vaccine, scheduling immunizations, and also providing periodic updates to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read